Contemporary management of stable coronary artery disease
DT Bertolone, E Gallinoro, G Esposito… - … & Cardiovascular …, 2022 - Springer
… ) patients allowing us to focus specifically on ischemia-inducing stenoses. Finally, we also
discuss contemporary … for the management of patients with stable coronary artery disease. …
discuss contemporary … for the management of patients with stable coronary artery disease. …
Contemporary medical management of peripheral artery disease
MP Bonaca, NM Hamburg, MA Creager - Circulation research, 2021 - Am Heart Assoc
… with cardiovascular disease and is associated with an arteritis similar to Buergers disease,
nonatherosclerotic peripheral artery disease; … of background clopidogrel use highlighting the …
nonatherosclerotic peripheral artery disease; … of background clopidogrel use highlighting the …
[HTML][HTML] The role of clopidogrel in 2020: a reappraisal
G Patti, G Micieli, C Cimminiello… - Cardiovascular …, 2020 - hindawi.com
… of peripheral arterial disease, vascular death, or rehospitalization for acute ischemia compared
with placebo plus clopidogrel over 18 … Sharma et al., “Contemporary use of ticagrelor in …
with placebo plus clopidogrel over 18 … Sharma et al., “Contemporary use of ticagrelor in …
Contemporary Use of Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A GRACE Risk Score …
M Qiu, K Na, Z Qi, H Zhou, P Li, K Xu, B Wang… - Mayo Clinic …, 2023 - Elsevier
… Variables selected for inclusion into the model were patient characteristics including age, …
prior stroke, peripheral arterial disease, prior coronary artery bypass grafting, and tobacco use; …
prior stroke, peripheral arterial disease, prior coronary artery bypass grafting, and tobacco use; …
Contemporary review of antithrombotic therapy in peripheral artery disease
CN Hess, MP Bonaca - Circulation: Cardiovascular Interventions, 2020 - Am Heart Assoc
… in patients with PAD. In this article, we provide a contemporary review of data supporting the
use … and Acetylsalicylic Acid in Bypass Surgery for Peripheral Arterial disease), clopidogrel …
use … and Acetylsalicylic Acid in Bypass Surgery for Peripheral Arterial disease), clopidogrel …
Complexity of antiplatelet therapy in coronary artery disease patients
P Sabouret, MP Savage, D Fischman… - … Journal of Cardiovascular …, 2021 - Springer
… (ie clopidogrel, prasugrel, or ticagrelor), remains the cornerstone of treatment for patients with
coronary artery disease (… for secondary coronary prevention after either an acute coronary …
coronary artery disease (… for secondary coronary prevention after either an acute coronary …
Dual antiplatelet therapy in coronary artery disease: from the past to the future prospective
A Mangieri, F Gallo, A Sticchi, AA Khokhar… - Cardiovascular …, 2020 - Springer
… events in patients with coronary artery disease when compared to clopidogrel. However, their
… challenges in the contemporary use of DAPT. Future studies are required to clarify, which …
… challenges in the contemporary use of DAPT. Future studies are required to clarify, which …
Association of ticagrelor vs clopidogrel with major adverse coronary events in patients with acute coronary syndrome undergoing percutaneous coronary intervention
… , multivessel coronary artery disease on coronary angiography, … , contemporary,
population-based cohort study of patients … Given that patients who underwent coronary artery …
population-based cohort study of patients … Given that patients who underwent coronary artery …
Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease
M Bossard, P Gao, W Boden, G Steg, JF Tanguay… - Heart, 2021 - heart.bmj.com
… -dose versus standard-dose clopidogrel regimens in these patients, we found no evidence
of … (MINOCA): insights from the Alberta contemporary acute coronary syndrome patients …
of … (MINOCA): insights from the Alberta contemporary acute coronary syndrome patients …
Cangrelor: clinical data, contemporary use, and future perspectives
… Inhibition) program, where it was compared with different clopidogrel regimens, and it is
currently indicated for use in patients with coronary artery disease undergoing percutaneous …
currently indicated for use in patients with coronary artery disease undergoing percutaneous …